Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Current Deferred Revenue (2009 - 2026)

Icon's (ICLR) quarterly Current Deferred Revenue came in at $1.6 billion in Q2 2026, up 5.86% year-over-year from $1.5 billion in Q2 2025, and up 3.6% quarter-over-quarter from $1.5 billion in Q1 2026.

Analysis

Icon (ICLR) Current Deferred Revenue (2009 - 2026) Analysis & Trends

Icon (ICLR) has reported Current Deferred Revenue for 18 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Deferred Revenue rose 5.86% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 5.86% increase from a year earlier, with the FY2025 full-year figure at $1.6 billion, up 5.64% from the prior year.
  • Current Deferred Revenue was $1.6 billion for Q2 2026 at Icon, up from $1.5 billion in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $14.3 billion in Q3 2023 and troughed at $1.5 billion in Q4 2024.
  • A 5-year average of $5.6 billion and a median of $1.6 billion in 2024 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue jumped 110.61% in 2022 and tumbled 88.91% in 2024, its largest moves.
  • Over 5 years, Current Deferred Revenue stood at $1.5 billion in 2022, then grew by 3.91% to $1.6 billion in 2023, then slipped by 6.31% to $1.5 billion in 2024, then increased by 5.64% to $1.6 billion in 2025, then grew by 3.4% to $1.6 billion in 2026.
  • The last three Current Deferred Revenue figures came in at $1.6 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.6 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Bn
Mar 31, 2026 1.55 Bn
Dec 31, 2025 1.55 Bn
Sep 30, 2025 1.53 Bn
Jun 30, 2025 1.51 Bn
Mar 31, 2025 1.50 Bn
Dec 31, 2024 1.47 Bn
Sep 30, 2024 1.59 Bn
Jun 30, 2024 1.60 Bn
Mar 31, 2024 1.71 Bn
Dec 31, 2023 1.57 Bn
Sep 30, 2023 14.30 Bn
Jun 30, 2023 13.90 Bn
Mar 31, 2023 13.80 Bn
Dec 31, 2022 1.51 Bn
Sep 30, 2022 13.50 Bn
Jun 30, 2022 13.90 Bn
Mar 31, 2022 13.60 Bn
Dec 31, 2021 1.32 Bn
Sep 30, 2021 13.00 Bn